Observational studies are critical tools in clinical research and public health response, but challenges arise in ensuring ...

Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically ...

The diagnosis of hepatitis A virus (HAV) infection is based on the detection of anti-HAV IgM. Shortcomings of this serological approach include the persistence of IgM after normalization of liver ...

Sparked by a flurry of executive orders in the first week of taking power, and evolving at dizzying pace, the new US administration has taken a wrecking ball to health-related services and research ...

With several drugs in use that inhibit the hepatitis B virus polymerases (nucleos(t)ide analogues (or NUCs)), some argue that new direct-acting antiviral drugs, and new NUCs in particular ...

An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a phase 3 assessment next year to see if it could offer a ...

GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...

Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically modified to carry a human gene—for studying hepatitis B virus.

A virus originally found in animals, mpox – which causes the disease of the same name – is now circulating in humans.

VANCOUVER - British Columbia is seeing “peaking influenza activity” even as other respiratory illnesses such as RSV and COVID-19 are in decline, and health officials are reminding people to ...

What’s the difference between influenza A and influenza B, and does it matter which you ... “You tend to have one or the other virus predominant at any given time,” said Anice Lowen, a ...